HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+9.73%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$1.46B
AUM Growth
+$1.46B
(-4.8%)
Cap. Flow
-$147M
Cap. Flow
% of AUM
-10.05%
Top 10 Holdings %
Top 10 Hldgs %
55.54%
Holding
75
New
24
Increased
12
Reduced
12
Closed
20
Top Buys
| 1 |
Viatris
VTRS
|
$64.7M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
$64.4M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$63.4M |
| 4 |
Merck
MRK
|
$58.8M |
| 5 |
ENDP
Endo International plc
ENDP
|
$52.2M |
Top Sells
| 1 |
AGN
ALLERGAN INC
AGN
|
$96.4M |
| 2 |
ARTC
ARTHROCARE CORP
ARTC
|
$95.6M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$65.8M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
$50.3M |
| 5 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$49.4M |
Sector Composition
| 1 | Healthcare | 74.33% |
| 2 | Financials | 5.64% |
| 3 | Technology | 1.7% |
| 4 | Consumer Staples | 0% |
| 5 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
1
DELISTED
Veradigm Inc. Common Stock
MDRX
| $151M | 9.11% | 8,400,000 -1,600,000 | -16% | -$28.8M |
|
|
2
Viatris
VTRS
$12.3B
| $100M | 6.02% | 2,050,000 +1,325,000 | +183% | +$64.7M |
|
|
WMGI
3
DELISTED
Wright Medical Group Inc
WMGI
| $96.3M | 5.79% | 3,100,000 +50,000 | +2% | +$1.55M |
|
4
eHealth
EHTH
$118M
| $82.6M | 4.97% | 1,625,000 -75,000 | -4% | -$3.81M |
|
|
SLXP
5
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $67.3M | 4.05% | 650,000 +250,000 | +63% | +$25.9M |
|
|
6
Merck
MRK
$210B
| $65.3M | 3.93% | 1,150,000 +1,035,900 | +908% | +$58.8M |
|
|
MDVN
7
DELISTED
MEDIVATION, INC.
MDVN
| $64.4M | 3.87% | +1,000,000 | New | +$64.4M |
|
|
MNK
8
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $63.4M | 3.81% | +1,000,000 | New | +$63.4M |
|
9
McKesson
MCK
$85.4B
| $61.8M | 3.72% | 350,000 -250,000 | -42% | -$44.1M |
|
10
Gilead Sciences
GILD
$140B
| $61M | 3.67% | 860,492 +685,492 | +392% | +$48.6M |
|
|
CBST
11
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $53M | 3.19% | 725,000 -675,000 | -48% | -$49.4M |
|
|
ENDP
12
DELISTED
Endo International plc
ENDP
| $52.2M | 3.14% | +760,100 | New | +$52.2M |
|
|
WBMD
13
DELISTED
WebMD Health Corp.
WBMD
| $51.8M | 3.11% | 1,250,000 +100,000 | +9% | +$4.14M |
|
|
TSRO
14
DELISTED
TESARO, Inc.
TSRO
| $41.3M | 2.48% | +1,400,000 | New | +$41.3M |
|
|
CFN
15
DELISTED
CAREFUSION CORPORATION
CFN
| $40.2M | 2.42% | +1,000,000 | New | +$40.2M |
|
16
Agilent Technologies
A
$35.7B
| $39.1M | 2.35% | 700,000 +75,000 | +12% | +$4.19M |
|
|
NUVA
17
DELISTED
NuVasive, Inc.
NUVA
| $38.4M | 2.31% | 1,000,000 +225,000 | +29% | +$8.64M |
|
|
CLVS
18
DELISTED
Clovis Oncology, Inc.
CLVS
| $32.9M | 1.98% | 475,000 +376,437 | +382% | +$26.1M |
|
19
Myriad Genetics
MYGN
$593M
| $29.2M | 1.76% | 854,900 +204,900 | +32% | +$7.01M |
|
|
CTRX
20
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $28M | 1.68% | +625,000 | New | +$28M |
|
|
NUAN
21
DELISTED
Nuance Communications, Inc.
NUAN
| $24.9M | 1.5% | +1,450,000 | New | +$24.9M |
|
22
Icon
ICLR
$13.8B
| $20.7M | 1.24% | +434,400 | New | +$20.7M |
|
23
Acadia Pharmaceuticals
ACAD
$4.38B
| $17M | 1.02% | +700,000 | New | +$17M |
|
24
Brookdale Senior Living
BKD
$1.83B
| $16.8M | 1.01% | +500,000 | New | +$16.8M |
|
|
AMRI
25
DELISTED
Albany Molecular Research Inc
AMRI
| $16.7M | 1.01% | +900,000 | New | +$16.7M |
|